DJIA 15,112.19 -206.04 -1.35%
NASDAQ 3,443.20 -38.98 -1.12%
S&P 500 1,628.93 -22.88 -1.39%
market minute promo

7.61 0.10 (1.33%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ARNA $7.61 1.33%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $7.81
Previous Close $7.51
Daily Range $7.50 - $7.83
52-Week Range $6.95 - $13.50
Market Cap $1.7B
P/E Ratio -20.86
Dividend (Yield) $0.00 (0.0%)
Volume 7,044,713
Average Daily Volume 5,816,065
Current FY EPS -$0.12

Sector

Healthcare

Industry

Drugs

Arena Pharmaceuticals, Inc. (ARNA) Description

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Website: http://www.arenapharm.com/

News & Commentary Rss Feed

It's Official: Obesity Is a Disease

At least according to the American Medical Association.

Arena Pharmaceuticals CEO Presents at Wells Fargo Health Care Conference (Transcript)

Obesity Sector Gets New Shoes

Healthcare Stocks Inching Lower; Weight Loss Drug-Makers Climbing After AMA Labels Obesity as Diseas

Healthcare Stocks Inching Lower; Weight Loss Drug-Makers Climbing After AMA Labels Obesity as Disease

Senators Carper, Murkowski, Representatives Cassidy, Kind Introduce Bill to Help Reduce Obesity

Sector Update: Healthcare

What Investors Need To Know About The Efficacy Of Belviq

The Top 5 Diseases Caused by Obesity

Obesity accounts for 21% of all health-care expenditures annually, and it's a leading risk factor for these five diseases.

Arena Pharmaceuticals: A Trading Vehicle, At Best

Arena's Belviq Does Not Fare Well With Consumer Reports

See More ARNA News...

ARNA's Top Competitors

ARNA $7.61 (1.33%)
Current stock: ARNA
AMGN $99.18 (-2.29%)
Current stock: AMGN
GILD $50.60 (-2.58%)
Current stock: GILD
BIIB $203.80 (-3.32%)
Current stock: BIIB